Status:
COMPLETED
MiVacunaLA: an Intervention to Improve COVID-19 Vaccination Behaviors Among Latinos
Lead Sponsor:
Cedars-Sinai Medical Center
Collaborating Sponsors:
Pepperdine University
Conditions:
COVID-19 Pandemic
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The aim of this study is to determine whether a community-informed, linguistically and culturally tailored educational program delivered via mobile phone is effective in improving vaccination behavior...
Detailed Description
We conducted a community-based randomized clinical trial with a wait list control group among adult Latino parents or caregivers in East and South Los Angeles. Participants completed an online demogra...
Eligibility Criteria
Inclusion
- self-identified as Latino/a,
- were 18 years or older,
- had at least one unvaccinated child of any age (17 or younger), and
- had the means to receive messages and review educational material online, such as a text-capable mobile phone with internet access
Exclusion
- Unable to receive information via mobile text or computer.
- Does not speak English or Spanish.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
468 Patients enrolled
Trial Details
Trial ID
NCT05234372
Start Date
June 1 2022
End Date
December 31 2022
Last Update
December 16 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Los Angeles
Los Angeles, California, United States, 90095
2
Pepperdine University
Malibu, California, United States, 90263